Wegovy's New Price in the UK: Making Sense of the Numbers

Why Wegovy quotes differ so widely between providers

The starter dose of semaglutide (0.25mg) typically appears at the lower end of any provider's pricing table, while the 1.7mg and 2.4mg maintenance doses sit at the top. That graduated structure is legitimate, higher doses cost more to manufacture and supply. What varies more problematically is what a given quote actually covers. Some headline prices include the consultation, prescription, and aftercare. Others do not. A low number that excludes prescription fees, a clinical review charge, and a delivery fee can easily end up costing more than a higher all-in number, once everything is added at checkout.

A question our prescribers hear most weeks: "I found it cheaper somewhere, is it the same thing?" The honest answer is: sometimes yes, sometimes no, and sometimes the answer is unknowable, because the supply chain behind an unusually cheap listing is not always visible to the buyer. For detail on how dose affects the monthly figure, the full breakdown of Wegovy cost by dose is worth reading before you compare quotes.

The NICE appraisal of semaglutide (TA875) confirms that semaglutide for weight management is a prescription-only medicine requiring clinical assessment; no legitimate provider can skip that step, and any price that seems to do so is a signal to pause.

What the new Wegovy pricing landscape looks like after 2025

The UK private market for GLP-1 medicines shifted in 2025. When Eli Lilly raised Mounjaro's list price from September of that year (with the highest-dose pen's price moving from around £122 to around £330) the ripple effect across semaglutide pricing was real and widely reported, and our new Wegovy prices page sets out exactly how that recalibration has landed across all doses. The approval of the 7.2mg semaglutide pen by the MHRA in April 2026 added another tier to the pricing structure, one that sits above the standard 2.4mg maintenance dose.

For most people starting treatment, the price they pay in month one (at the starter dose) will be lower than what they pay at maintenance. That is not a hidden fee (it reflects the titration schedule) but it is worth understanding before you budget. The per-pen pricing context page explains how to read those numbers clearly. Current pricing at nume is shown on the treatment page, not in this article, because what you're quoted should follow a clinical assessment of which dose is right for you specifically.

NHS access to Wegovy exists but remains limited: NICE's recommendation under TA875 applies within specialist weight management services, with conditions attached including a maximum two-year duration. Waiting lists are commonly long. For people who don't meet NHS criteria or prefer not to wait, a regulated private route (through a pharmacy you can verify on the GPhC register) is the legal alternative.

What to weigh up when you're comparing prices

Price is one variable among several. The others tend to matter more once you're in treatment. Is there a real prescriber reviewing your case, or an algorithm approving requests? What happens if you have a question on a Saturday evening? Is your next dose reviewed clinically before dispatch, or auto-shipped? These are practical questions, not abstract ones, they affect your safety and your results.

At nume, we are not the cheapest option, and that is a deliberate position. One transparent price covers the consultation, prescription, delivery and ongoing clinical support; there are no subscriptions and no auto-renewals. Every repeat order is reviewed by a prescriber before it goes out. Our about us page explains how the service is structured, and you can verify our pharmacy on the GPhC register at registration number 9012878. If price is your primary concern, we'd rather you know that clearly now than discover it later. If clinical rigour matters to you, starting a free consultation costs you nothing.

For the specific 1mg dose pricing context (relevant if you're mid-titration or transferring from another provider) the Wegovy 1mg price page covers that in detail. A broader overview of the treatment itself is on the weight loss treatments overview.

Why 'cheapest' is the wrong question for a prescription medicine

The MHRA has been unambiguous: fake weight-loss pens have been seized in significant quantities across the UK, including counterfeit tirzepatide manufactured domestically and removed from the supply chain. Some fake pens have contained insulin. The risk is not theoretical. When a seller offers a GLP-1 medicine at a price that seems implausible, without a verifiable prescription process, that is a red flag, not a bargain.

A small saving on a medicine you inject weekly is not the measure that keeps you safe. The right questions are: can I verify this pharmacy on the GPhC register? Is there a named prescriber reviewing my case? Is the supply chain licensed in the UK? If you're unsure about any seller, the MHRA's Yellow Card scheme allows you to report suspect sources. For a full comparison of what legitimate providers include in their pricing, the Wegovy price overview is a useful reference. And if you'd like to check your eligibility and discuss treatment with a prescriber, your free consultation is here.